Correlation Between Vertex Pharmaceuticals and Innovent Biologics

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals and Innovent Biologics, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Innovent Biologics.

Diversification Opportunities for Vertex Pharmaceuticals and Innovent Biologics

0.59

Correlation Coefficient

Vertex Pharmaceuticals  Innovent Biologics

Very weak diversification

The 3 months correlation between Vertex and Innovent is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Innovent Biologics go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Innovent Biologics

Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 0.39 times more return on investment than Innovent Biologics. However, Vertex Pharmaceuticals is 2.58 times less risky than Innovent Biologics. It trades about 0.25 of its potential returns per unit of risk. Innovent Biologics is currently generating about 0.08 per unit of risk. If you would invest  40,527  in Vertex Pharmaceuticals on December 21, 2024 and sell it today you would earn a total of  9,793  from holding Vertex Pharmaceuticals or generate 24.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	93.75%
Values	Daily Returns

Vertex Pharmaceuticals  vs.  Innovent Biologics

Vertex Pharmaceuticals

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Vertex Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Innovent Biologics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Innovent Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Innovent Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vertex Pharmaceuticals and Innovent Biologics

The main advantage of trading using opposite Vertex Pharmaceuticals and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.

The idea behind Vertex Pharmaceuticals and Innovent Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.